¾È³çÇϼ¼¿ä. À̹ø ÁÖ Åä¿äÀÏ ¼¼¹Ì³ª ¹ßÇ¥ÀÚ ÀÌÁ¤Ã¶ÀÔ´Ï´Ù.
Á¦°¡ À̹ø ÁÖ ¹ßÇ¥ÇÒ ³í¹®Àº 2022³â 5¿ù Cell Host & Microbe¿¡ ÃâÆÇµÈ 'Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics'ÀÔ´Ï´Ù.
Live biotherapeutic product(LBP)´Â Àå³»¿¡¼ microbial compositionÀ» º¯È½ÃÅ°°í host microbiome°úÀÇ interactionÀ¸·Î ÀÎÇØ metabolitesµéÀ» Çü¼ºÇÑ´Ù´Â Á¡ÀÌ ¾Ë·ÁÁ® ÀÖÀ¸¸ç, Àå³» dysbiosesÀÇ Ä¡·áÇϱâ À§ÇÑ ÀÏȯÀ¸·Î LBP¸¦ È°¿ëÇÑ Ä¡·á¹ý¿¡ ´ëÇÑ ¿¬±¸°¡ È°¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù.
°ø¿©ÀÚ¸¦ ÅëÇØ ¼ö¿©ÀÚ¿¡ Àü´ÞµÈ microbiomeµéÀº ¼ö¿©ÀÚÀÇ Àå³»¿¡¼ »ýÁ¸ÇÒ ¼ö´Â ÀÖÁö¸¸, gut ³»¿¡¼ transit timeÀÌ ÇÑÁ¤ÀûÀÌ°í engraftment¸¦ Çü¼ºÇÏ¿© Áö¼ÓÀûÀ¸·Î ¿µÇâÀ» ¹ÌÄ¡´ÂÁö¿¡ ´ëÇÑ Á¡Àº ¾ÆÁ÷ ¾Ë·ÁÁø ¹Ù°¡ ¸¹Áö ¾Ê½À´Ï´Ù.
¶§¹®¿¡ ÃÖ±Ù ¸¹Àº ¿¬±¸µé¿¡¼´Â ¼ö¿©ÀÚ ³» °ø¿©ÀÚÀÇ microbiome colonizationÀ» Àß ÀÏÀ¸Å°±â À§ÇØ antibiotics¸¦ ó¸®ÇÏ¿© microbiota¸¦ Á¦°ÅÇÑ µÚ, microbiomeÀ» Àü´ÞÇÏ´Â ¹æ½ÄÀ» È°¿ëÇÏ°í ÀÖ½À´Ï´Ù.
ÇØ´ç ¿¬±¸ÁøÀº human oligosaccharides (HMO)¿Í Bifidobacterium longum subsp. infantis (B. infantis)¸¦ ÅëÇÑ synbiotics È°¿ë¿¡ ´ëÇÑ ¿¬±¸¸¦ ÁøÇàÇßÀ¸¸ç, Ç×»ýÁ¦ »çÀü Åõ¿© ¹× ºÎÀÛ¿ë ¾øÀÌ prebiotics dependentÇÏ°Ô target microbiomeÀÌ engraftment¸¦ Àß ÀÌ·ç¾úÀ½À» È®ÀÎÇÏ¿´½À´Ï´Ù.
ÇØ´ç synbioticÀÇ È°¿ëÀº »ç¶÷ÀÇ Àå³»¿¡¼ metaboliteµéÀÇ º¯È¿¡ °ü¿©ÇÏ¿´À¸¸ç, gnotobiotics ¸ðµ¨À» È°¿ëÇÑ mouse¿¡¼µµ engraftment Çü¼º ¹× butyrateÀÇ »ý¼ºÀÌ ÀϾÀ½À» È®ÀÎÇÏ¿´½À´Ï´Ù.
Synbiotics ¿Í enteropathogen°úÀÇ in vitro co-culture¸¦ ÅëÇØ enteropathogenµéÀÇ ¾ïÁ¦¿¡ °ü¿©ÇÏ¿´À¸¸ç, ÀÌ·¯ÇÑ °á°ú¸¦ ¹ÙÅÁÀ¸·Î Èʳ¯ dysbioses¸¦ ¿ÏȽÃÅ°±â À§ÇÑ Ä¡·á¹ýÀ¸·Î synbioticsÀÇ È°¿ëÀ» Á¦½ÃÇÏ°í ÀÖ½À´Ï´Ù.
¸é¿ªÇÐÀûÀÎ ÁöÇ¥µéÀ» È®ÀÎÇÏ´Â ½ÇÇèµéÀÌ ºÎÁ·ÇÏ´Ù´Â Á¡¿¡¼ ´Ù¼Ò ¾Æ½¬¿î Á¡ÀÌ ÀÖ¾úÁö¸¸, ÇöÀç Á¦°¡ ½ÇÇè¿¡¼ ÀÌ¿ëÇÏ´Â synbiotics ÄÁ¼Á ¹× ÃÖ±Ù ¿¬±¸ µ¿Çâ ¹× ½ÇÇè¹ý¿¡ ´ëÇØ ÀÌÇØÇÏ°íÀÚ ÇØ´ç ³í¹®À» ¼±Á¤ÇÏ¿´½À´Ï´Ù.
¿½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
¸µÅ©:
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(22)00207-4